Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma. [electronic resource]
Producer: 20190306Description: 26-30 p. digitalISSN:- 1743-7563
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Brain Neoplasms -- drug therapy
- Female
- Humans
- Ipilimumab -- administration & dosage
- Male
- Melanoma -- drug therapy
- Middle Aged
- Nivolumab -- administration & dosage
- Prognosis
- Retrospective Studies
- Survival Rate
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.